Sponsor:
Stanford University
Code:
NCT06635746
Conditions
Fetal Alcohol Spectrum Disorders
Eligibility Criteria
Sex: All
Age: 18 - 40
Healthy Volunteers: Accepted
Interventions
Vinpocetine
Brief summary:
Conditions
Fetal Alcohol Spectrum Disorders
Study ID
NCT06635746
Start date
Oct 1, 2025
Status verified date
Nov, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 40
Healthy Volunteers: Accepted
Enrollment
16 participants
Anticipated
Allocation
Non randomized
Intervention Model
Single group
Primary purpose
Treatment
Arms
experimental: Vinpocetine
experimental: Pharmacokinetics for TID dosing.
Interventions
Vinpocetine
Primary outcome measure
Central contacts
Locations
Stanford University
Recruiting
Palo Alto, California, United States, 94304
Contacts
Sponsor
Stanford University
Last update posted
Nov 19, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by Stanford University on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.